CELEX: 32021M10202
Language: en
Date: 2021-06-16 00:00:00
Title: Commission Decision of 16/06/2021 declaring a concentration to be compatible with the common market (Case No COMP/M.10202 - EQT / INVESTINDUSTRIAL / JV) according to Council Regulation (EC) No 139/2004 (Only the English text is authentic)

EUROPEAN COMMISSION
                                                                Brussels,16.6.2021
                                                                C(2021) 4513 final
                                                                                 PUBLIC VERSION
                                                                Igenomix, S.L.U.
                                                                Calle Narcís Monturiol Estarriol 11
                                                                Parcels B, Edificio Europark,
                                                                Parque Tecnológico de Paterna
                                                                46980 Paterna
                                                                Spain
                                                                Universal Clinics, S.L.
                                                                Calle Jose Silva 9B
                                                                Madrid
                                                                Spain
Subject:        Case M.10202 – EQT / INVESTINDUSTRIAL / JV
                Commission decision pursuant to Article 6(1)(b) of Council Regulation
                                       1
                (EC) No 139/2004 and Article 57 of the Agreement on the European
                                    2
                Economic Area
Dear Sir or Madam,
1.      On 21 May 2021, the European Commission received notification of a proposed
        concentration pursuant to Article 4 of the Merger Regulation by which the
        undertaking Igenomix, S.L.U. (‘Igenomix’, Spain), solely controlled by EQT AB
        (‘EQT’, Sweden), and Universal Clinics, S.L. (‘Universal Clinics’, Spain), solely
        controlled by Investindustrial S.A. (‘Investindustrial’, Luxembourg), acquire within
        the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control over a
        newly created joint venture (the ‘JV’ ) by way of purchase of shares.3
2.      The business activities of the undertakings concerned are:
             − for EQT: management of investment funds. Portfolio companies controlled by
                 EQT include notably Igenomix, a company dedicated to the business of
                 genetic and molecular diagnostics, as well as clinical and complementary
1       OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’). With effect from 1 December 2009, the Treaty on
        the Functioning of the European Union (‘TFEU’) has introduced certain changes, such as the
        replacement of ‘Community’ by ‘Union’ and ‘common market’ by ‘internal market’. The terminology
        of the TFEU will be used throughout this decision.
2       OJ L 1, 3.1.1994, p. 3 (the ‘EEA Agreement’).
3       Publication in the Official Journal of the European Union No C 205, 31.05.2021, p. 9.
Commission européenne, DG COMP MERGER REGISTRY, 1049 Bruxelles, BELGIQUE
Europese Commissie, DG COMP MERGER REGISTRY, 1049 Brussel, BELGIË
Tel: +32 229-91111. Fax: +32 229-64301. E-mail: COMP-MERGER-REGISTRY@ec.europa.eu.
 ---pagebreak---            analyses, specialized in the reproductive sector and in vitro fertilisation related
           testing,
       − for Investindustrial: management of investment funds. Portfolio companies
           controlled by Investindustrial include notably Universal Clinics, a company
           active in reproduction medicine through the ownership, operation and
           development of health clinics in Spain, Italy, Czech Republic and Sweden,
       − for the JV: development and commercialisation of a non-invasive embryo
           culture medical device to be used by in vitro fertilization laboratories.
3. After examination of the notification, the European Commission has concluded that
   the notified operation falls within the scope of the Merger Regulation and of
   paragraph 5(a) of the Commission Notice on a simplified procedure for treatment of
   certain concentrations under Council Regulation (EC) No 139/2004.4
4. For the reasons set out in the Notice on a simplified procedure, the European
   Commission has decided not to oppose the notified operation and to declare it
   compatible with the internal market and with the EEA Agreement. This decision is
   adopted in application of Article 6(1)(b) of the Merger Regulation and Article 57 of
   the EEA Agreement.
                                                   For the Commission
                                                   (Signed)
                                                   Olivier GUERSENT
                                                   Director-General
4  OJ C 366, 14.12.2013, p. 5.
                                               2